Inventor

Carl F. Ware

Inventor
Solana Beach, CA, US

Overview

19→
Patents
1997–2021
Patent span
Human necessities
Primary field (CPC A)

Patents· 19 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes27%
C07KPeptides27%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations20%
G01NInvestigating or analysing materials by determining their chemical or physical properties13%
C12NMicroorganisms or enzymes11%
Y02ATechnologies for adaptation to climate change1%
PatentTitleYear
10,961,297BTLA fusion protein agonists and uses thereof202110,759,863Modulation of gd T cells202010,717,765Compositions and methods for treating autoimmune and inflammatory disorders202010,220,081Methods of modulating HVEM, BTLA and CD160 cis complex response or signaling activity with soluble light polypeptide sequences201910,106,619Virus vaccination and treatment methods with OX40 agonist compositions20189,982,023Compositions and methods for treating autoimmune and inflammatory disorders20189,771,419'Antagonistic human light-specific human monoclonal antibodies'20179,700,606'HVEM/BTLA, HVEM/CD 160 and HVEM/gD cis complexes and methods of use'20179,694,058'Light-mediated anti-cell proliferative compositions and methods'20178,974,787'Antagonistic human light-specific human monoclonal antibodies'20158,461,307'Antagonistic human LIGHT-specific human monoclonal antibodies'20138,349,320'Compositions and methods for modulating responses mediated or associated with BTLA activity'20138,153,123'Method for restoring dendritic cell populations'20128,058,402'Antagonistic human LIGHT-specific human monoclonal antibodies'20117,575,745'Ligand for herpes simplex virus entry mediator and methods of use'20097,030,080'Lymphotoxin-β, lymphotoxin-β complexes, pharmaceutical preparations and therapeutic uses thereof'20065,795,964'Lymphotoxin-beta and lymphotoxin-beta complexes'19985,670,149'Lymphotoxin-.beta., Lymphotoxin-.beta. complexes, pharmaceutical preparations and therapeutic uses thereof'19975,661,004'Lymphotoxin-.beta., lymphotoxin-.beta. complexes, pharmaceutical preparations and therapeutic uses thereof'1997

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1997–2006Patents assigned to UNIV CALIFORNIA (4)· patent assignee history
1997–1998Patents assigned to BIOGEN INC (3)· patent assignee history
1997–2006Based in Riverside, CA, US· patent location history
2009–2015Patents assigned to JOLLA INST ALLERGY IMMUNOLOG (6)· patent assignee history
2009–2019Based in Solana Beach, CA, US· patent location history
2011–2018Patents assigned to WARE CARL F (7)· patent assignee history
2017–2019Patents assigned to LA JOLLA INST ALLERGY & IMMUNOLOGY (5)· patent assignee history
2018–2021Based in La Jolla, CA, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
WARE CARL Fself72011–2018
JOLLA INST ALLERGY IMMUNOLOG62009–2015
LA JOLLA INST ALLERGY & IMMUNOLOGY52017–2019
UNIV CALIFORNIA41997–2006
BIOGEN INC31997–1998
Locations
LocationPatentsSpan
Solana Beach, California, US112009–2019
La Jolla, California, US42018–2021
Riverside, California, US41997–2006